US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Pharmaceuticals Company Reports Industry Research & Market Reports

1  2  3    5    7  8  9  10  
VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of VentiRx Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Alethia Biotherapeutics Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Celsus Therapeutics Plc - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Celsus Therapeutics Plc’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Molecular Design International, Inc. - Product Pipeline Review - 2014
9/10/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Design International, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
Grupo Ferrer Internacional, S.A.: Ingredients - Company Profile & SWOT Report
9/19/2014 | published by: Canadean Ltd
... its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, mergers & acquisitions, recent developments, key employees as well as company locations and subsidiaries. Summary ...  |  read more...
USD 125
Sangui BioTech International, Inc. (SGBI) - Financial and Strategic SWOT Analysis Review
9/9/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 300
IOL Chemicals and Pharmaceuticals Limited (IOLCP) - Financial and Strategic SWOT Analysis Review
9/9/2014 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
SEE Pharmaceutical Market (Industry Report)
9/11/2014 | published by: SeeNews - Research & Profiles
... the leading companies, total workforce, and supply and demand specifics. It brings to the readers high added value by providing a detailed picture of nationwide industry investments and forward-looking forecasts and trends that must be ...  |  read more...
USD 1,300
Pharmaceuticals manufacturers in Slovenia in 2012 (Industry Report)
9/11/2014 | published by: SeeNews - Research & Profiles
... list of the leading companies, total workforce, and supply and demand specifics. It brings to the readers high added value by providing a detailed picture of nationwide industry investments and forward-looking forecasts and trends that ...  |  read more...
USD 680
Laboratoires Adwya in Consumer Health (Tunisia)
9/12/2014 | published by: Euromonitor International
... launch more generic products in the forecast period. The company also plans to focus on securing more tenders for the supply of medicines to hospitals/healthcare units. The company is also planning to invest nearly TND1 ...  |  read more...
USD 150
Maphar Laboratoires SA in Consumer Health (Morocco)
9/10/2014 | published by: Euromonitor International
... efficiency. The company’s mid-term management plan aims to enhance its research and development department in order to increase its level of new product development. The company also aims to benefit further from its leading position ...  |  read more...
USD 150
Saidal Algerie SpA in Consumer Health (Algeria)
9/9/2014 | published by: Euromonitor International
... agreements with global brands in pharmaceuticals. In addition, the company is expected to benefit from ongoing expansion in its production capacity, thanks to a hefty government investment in 2011. The company plans to double its ...  |  read more...
USD 150
Teriak Laboratoires Tunisie in Consumer Health (Tunisia)
9/12/2014 | published by: Euromonitor International
... consumers trade up within consumer health. The company is expected to particularly benefit from representing leading consumer health brand Panadol, with this set to further gain share. However, the company's new product development is expected ...  |  read more...
USD 150
Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture (World)
9/10/2014 | published by: Euromonitor International
... disruptions and unfavourable market conditions in key geographies have hindered recent performance, these companies have taken steps to promote future success. In April 2014, GSK and Novartis announced plans to create a consumer health joint ...  |  read more...
USD 520
Sigma-Tau S.p.A. - Strategic SWOT Analysis Review
9/9/2014 | published by: GlobalData
... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ...  |  read more...
USD 125
Aesica Pharmaceuticals Limited - Strategic SWOT Analysis Review
9/9/2014 | published by: GlobalData
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ...  |  read more...
USD 125
Oryzon Genomics S.A. - Product Pipeline Analysis, 2014 Update
9/4/2014 | published by: GlobalData
... diagnostics, personalized medicine and therapy fields. Oryzon’s diagnostic products include GynEC-DX for endometrial cancer; Cxbladder for bladder cancer; and ColoBRAF for colorectal cancer. The company produces NCEs and monoclonal antibodies for neurogeneration and cancer. It ...  |  read more...
USD 750
Bigtec Labs - Product Pipeline Analysis, 2014 Update
9/4/2014 | published by: GlobalData
... Trueprep-MAG is a battery-operated sample processing device. The company’s Truelab Uno is an automated device that performs real-time PCR using truenat microchips. Its products are manufactured and marketed by Molbio Diagnostics. The company’s research and ...  |  read more...
USD 750
Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2014 Update
9/4/2014 | published by: GlobalData
... provide critical genomic information to healthcare professionals, biopharma companies, and cancer centers. The company provides clinical services such as test menu, complete program, expand DX and summation report. It collaborates with Cleveland Clinic, Dana Farber ...  |  read more...
USD 750
Green Cross Corporation (006280) - Financial and Strategic SWOT Analysis Review
8/26/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Almirall, S.A. (ALM) - Financial and Strategic SWOT Analysis Review
9/2/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Novavax, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Catalent Pharma Solutions, Inc. (formerly Cardinal Health Pharmaceutical Technologies and Services) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Catalent Pharma Solutions, Inc. (formerly Cardinal Health Pharmaceutical Technologies and ...  |  read more...
USD 350
Nycomed SICAR S.C.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Nycomed SICAR S.C.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cornerstone Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
1  2  3    5    7  8  9  10